Tradename | Company | Number | Date | Products |
---|---|---|---|---|
MODURETIC 5-50 | Merck KGaA | N-018201 DISCN | 1982-01-01 | 1 products, RLD |
Brand Name | Status | Last Update |
---|---|---|
amiloride hydrochloride | ANDA | 2023-11-28 |
amiloride hydrochloride and hydrochlorothiazide | ANDA | 2023-02-04 |
amiloride hydrocloride | New Drug Application | 2021-12-11 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypertension | D006973 | EFO_0000537 | I10 | 3 | 1 | 5 | 6 | 8 | 23 |
Chronic renal insufficiency | D051436 | — | N18 | — | 1 | — | 2 | — | 3 |
Essential hypertension | D000075222 | — | I10 | — | — | — | 1 | 1 | 2 |
Proteinuria | D011507 | HP_0000093 | R80 | 1 | — | — | 1 | — | 2 |
Prehypertension | D058246 | — | — | — | — | 1 | 1 | — | 2 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | — | 1 | — | 1 |
Bipolar disorder | D001714 | EFO_0000289 | F30.9 | — | — | — | 1 | — | 1 |
Autosomal dominant polycystic kidney | D016891 | EFO_1001496 | Q61.2 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Heart failure | D006333 | HP_0001635 | I50 | 2 | — | 1 | — | — | 3 |
Cardiovascular diseases | D002318 | HP_0001626 | — | — | — | 2 | — | — | 2 |
Insulin resistance | D007333 | HP_0000855 | E88.819 | — | 1 | 1 | — | 1 | 2 |
Coronary disease | D003327 | — | — | — | 1 | 1 | — | — | 1 |
Coronary artery disease | D003324 | — | I25.1 | — | 1 | 1 | — | — | 1 |
Primary hyperparathyroidism | D049950 | EFO_0008519 | E21.0 | — | 1 | 1 | — | — | 1 |
Sleep apnea syndromes | D012891 | HP_0010535 | G47.3 | — | — | 1 | — | — | 1 |
Obstructive sleep apnea | D020181 | EFO_0003918 | G47.33 | — | — | 1 | — | — | 1 |
Overweight | D050177 | — | E66.3 | — | 1 | 1 | — | — | 1 |
Nephrotic syndrome | D009404 | EFO_0004255 | N04 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Cystic fibrosis | D003550 | EFO_0000390 | E84 | 5 | 1 | — | — | 1 | 7 |
Optic neuritis | D009902 | EFO_0007405 | H46 | — | 2 | — | — | — | 2 |
Hypoparathyroidism | D007011 | HP_0000829 | E20 | — | 1 | — | — | — | 1 |
Chronic progressive multiple sclerosis | D020528 | EFO_0003840 | — | — | 1 | — | — | — | 1 |
Gitelman syndrome | D053579 | Orphanet_358 | N15.8 | 1 | 1 | — | — | — | 1 |
Migraine with aura | D020325 | EFO_0005295 | G43.1 | — | 1 | — | — | — | 1 |
Albuminuria | D000419 | EFO_0004285 | R80.9 | — | 1 | — | — | — | 1 |
Multiple sclerosis | D009103 | EFO_0003885 | G35 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Mucociliary clearance | D009079 | — | — | 3 | — | — | — | — | 3 |
Pharmacokinetics | D010599 | — | — | 1 | — | — | — | — | 1 |
Gastroesophageal reflux | D005764 | EFO_0003948 | K21 | 1 | — | — | — | — | 1 |
Heartburn | D006356 | — | R12 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Covid-19 | D000086382 | — | U07.1 | — | — | — | — | 1 | 1 |
Microvascular angina | D017566 | — | — | — | — | — | — | 1 | 1 |
Bone fractures | D050723 | EFO_0003931 | T14.8 | — | — | — | — | 1 | 1 |
Nephrogenic diabetes insipidus | D018500 | — | N25.1 | — | — | — | — | 1 | 1 |
Hyperaldosteronism | D006929 | HP_0011736 | E26 | — | — | — | — | 1 | 1 |
Diabetic nephropathies | D003928 | EFO_0000401 | — | — | — | — | — | 1 | 1 |
Acromegaly | D000172 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Amiloride |
INN | amiloride |
Description | Amiloride is a member of the class of pyrazines resulting from the formal monoacylation of guanidine with the carboxy group of 3,5-diamino-6-chloropyrazine-2-carboxylic acid. It has a role as a sodium channel blocker and a diuretic. It is a member of pyrazines, an organochlorine compound, an aromatic amine and a member of guanidines. It is a conjugate base of an amiloride(1+). |
Classification | Small molecule |
Drug class | epithelial sodium channel (ENaC) inhibitors, amiloride derivatives |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | N=C(N)NC(=O)c1nc(Cl)c(N)nc1N |
PDB | — |
CAS-ID | 2609-46-3 |
RxCUI | — |
ChEMBL ID | CHEMBL945 |
ChEBI ID | 2639 |
PubChem CID | 16231 |
DrugBank | DB00594 |
UNII ID | 7DZO8EB0Z3 (ChemIDplus, GSRS) |